Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02739958Completed
Randomised, open-label trial of propofol injection (veterinary) and dexmedetomidine in laryngeal cancer (2 arms), sponsored by Mansoura University. Primary endpoint: CD3 plasma level at 7 days. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02739958.